Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes.

Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypes.

BACKGROUND: Analysis of potentially different impact of Lopinavir/Ritonavir (LPV/r) on non-B subtypes is confounded by dissimilarities in the conditions existing in different countries. We retrospectively compared its impact on populations infected with subtypes B and C in Israel, where patients inf...

Full description

Bibliographic Details
Main Authors: Zehava Grossman, Jonathan M Schapiro, Itzchak Levy, Daniel Elbirt, Michal Chowers, Klaris Riesenberg, Karen Olstein-Pops, Eduardo Shahar, Valery Istomin, Ilan Asher, Bat-Sheva Gottessman, Yonat Shemer, Hila Elinav, Gamal Hassoun, Shira Rosenberg, Diana Averbuch, Keren Machleb-Guri, Zipi Kra-Oz, Sara Radian-Sade, Hagit Rudich, Daniela Ram, Shlomo Maayan, Nancy Agmon-Levin, Zev Sthoeger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3903498?pdf=render

Internet

http://europepmc.org/articles/PMC3903498?pdf=render

Similar Items